Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Mastercard launches AI-driven Agent Pay for Machines, enabling seamless automated payments with 30+ partners.

Market News
10 Jun 2026
Bitcoin
View Source
Bullish
pluang ai news

Mastercard has introduced Agent Pay for Machines (AP4M), a new payment system that allows AI agents and connected machines to autonomously authorize, coordinate, and settle transactions globally. This infrastructure supports continuous commerce without traditional checkouts, enabling businesses to automate recurring expenses and microtransactions at machine speed. The platform integrates identity checks, authorization rules, and supports payments via cards, accounts, and stablecoins, adding a crypto dimension to enterprise payments. With over 30 partners including Coinbase, Ripple, and Stripe, Mastercard aims to create a trusted framework for autonomous commerce, potentially expanding digital asset use in business workflows.

More News

Global Initiative on Loneliness and Connection hosts forum to tackle social division and loneliness worldwide

Global Initiative on Loneliness and Connection hosts forum to tackle social division and loneliness worldwide

The Global Initiative on Loneliness and Connection (GILC) convened the 2026 Global Connection Forum on June 17 to address the growing public health crisis of loneliness and social isolation, which contribute to serious health risks and societal divis...

Market News
Neutral
37 minutes ago
Metastatic prostate cancer market to grow strongly through 2036 with new targeted therapies emerging.

Metastatic prostate cancer market to grow strongly through 2036 with new targeted therapies emerging.

The metastatic prostate cancer market is shifting from traditional hormone therapies to precision, biomarker-driven treatments, including novel PARP inhibitors and PSMA-targeted radioligand therapies. The market, valued at $11.5 billion in 2025 in ma...

Market News
Bullish
1 hour ago
Over 30 pharma companies race to develop 35+ lupus nephritis drugs, advancing treatment options globally.

Over 30 pharma companies race to develop 35+ lupus nephritis drugs, advancing treatment options globally.

The lupus nephritis clinical trial landscape is rapidly expanding with more than 30 pharmaceutical companies developing over 35 drugs targeting this serious autoimmune kidney condition. Key players like Novartis, Simcere, and Regeneron are advancing ...

Market News
Bullish
1 hour ago
VINCI launches €200M share buyback program from June 11 to July 31, 2026

VINCI launches €200M share buyback program from June 11 to July 31, 2026

VINCI has initiated a share buyback program by signing an agreement with an investment services provider to repurchase its shares up to a limit of €200 million. The program runs from June 11 to July 31, 2026, with the purchase price capped by shareho...

Company Fundamentals
Bullish
1 hour ago
VINCI launches €200M share buyback program valid until July 31, 2026

VINCI launches €200M share buyback program valid until July 31, 2026

VINCI has initiated a share buyback program by signing an agreement with an investment service provider to repurchase its shares up to a value of €200 million. This program runs from June 11 to July 31, 2026, with purchase prices capped by the genera...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App